Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cell-regulating gene may predict survival outcomes for breast cancer patients

06.09.2006
A study led by researchers at Mount Sinai School of Medicine has shown that a cell-regulating gene overexpressed in about 30 to 50 percent of all breast cancers is associated with a better chance of survival and increased sensitivity to a cancer-fighting drug. The study appears in the September 6 issue of Journal of the National Cancer Institute.

Using mouse models, in vivo and in vitro tests revealed that the overexpression of a cell-regulating gene called cyclin D1 may actually be advantageous for some breast cancer patients because it suppresses the activity of another gene--STAT3--which promotes cell overgrowth and prevents harmful cells from dying, explains Doris Germain, PhD, Assistant Professor of Medicine.

Dr. Samuel Waxman, the Albert A. and Vera G. List Professor of Medicine, and Clinical Professor of Medicine (Hematology and Medical Oncology) and Oncological Sciences, Yuki Ishii, PhD, the study's first author and a post-doctoral fellow in molecular oncology, and Dr. Germain, collaborated with colleagues from Mount Sinai, and researchers from the Dana-Farber Cancer Institute in Boston and the Peter MacCallum Cancer Centre in Melbourne, Australia. They found that high levels of cyclin D1 increases sensitivity to bortezomib, a recently approved FDA drug used to treat multiple myeloma. The findings indicate that cyclin D1 could be a potential biological marker to help clinicians predict which breast cancer patients would respond favorably to bortezomib.

"Tumors occur because of a lack of control over cellular division," Dr. Germain explains. "Cyclin D1 promotes cell growth so you would think it would be an advantage to the tumor. But instead, we found that when cyclin D1 is overexpressed, it blocks STAT3. So cyclin D1 is inhibiting STAT3, which in turn, keeps the cancer from developing further."

Repressing STAT3 also increased a breast tumor's sensitivity to bortezomib, adds Dr. Waxman, indicating that bortezomib may be an alternative for women whose breast cancer has high levels of cyclin D1. "Our study provides a potential explanation for the beneficial effect of cyclin D1 in breast cancer and suggests that by amplifying this effect, bortezomib may be a useful treatment," he says. "A genetic profile of a patients' breast tumors could yield a great deal of information and help clinicians create more targeted treatments for their patients."

The findings were a surprise, Dr. Waxman says, because previous studies had suggested that the overexpression of cyclin D1 was associated with a poor prognosis in other types of cancers, including pancreatic cancer. Dr. Waxman says more research is needed to ascertain which groups of women have overexpressed cyclin D1. Clinical trials could then determine whether bortezomib would benefit these patients, he adds.

Mount Sinai Press Office | EurekAlert!
Further information:
http://www.mssm.edu

More articles from Studies and Analyses:

nachricht Innovative genetic tests for children with developmental disorders and epilepsy
11.07.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Oxygen loss in the coastal Baltic Sea is “unprecedentedly severe”
05.07.2018 | European Geosciences Union

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>